HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Figures Only Full Text Full Text (PDF) Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Lucidarme, O. Articles by Mattrey, R. F. Search for Related Content PubMed PubMed Citation Articles by Lucidarme, O. Articles by Mattrey, R. F.

Angiogenesis: Noninvasive Quantitative Assessment with Contrast-enhanced Functional US in Murine Model¹

¹ From the Departments of Radiology (O.L., Y.K., J.C., S.H.C., R.F.M.) and Medicine (J.V.), University of California, San Diego, Calif; and Department of Biostatistics, University Pierre et Marie Curie, Paris, France (J.L.G.). From the 2002 RSNA Annual Meeting. Received June 3, 2004; revision requested August 10; revision received April 21, 2005; accepted June 17; final version accepted July 29. Supported in part by Société Française de Radiologie. Address correspondence to R.F.M., MRI Institute, 410 Dickinson St, San Diego, CA 92103 (e-mail: rmattrey{at}ucsd.edu).

Purpose: To evaluate quantitative functional ultrasonography (US) in a murine gel model by using microbubble destruction kinetics to determine whether parametric indices provided with US could help assess angiogenesis.

Materials and Methods: Institutional Animal Subjects Committee approved experiments and procedures. In 36 normal mice, two 0.4-mL gel implants were placed subcutaneously on either side of spine. One implant contained 0.5, 1.0, or 1.5 µg human basic fibroblast growth factor (bFGF) per milliliter of gel. Functional US quantitative analysis of angiogenesis with microbubble contrast agent was performed on days 3, 6, 9, and 12; histologic data were collected. Time-intensity curve of implant was fitted to mathematic decay model to calculate fractional blood volume and fraction of blood replaced per unit of time. Microvascular density (MVD) and percentage of microvascular area (MVA) were measured after anti-CD31 staining. Spearman rank order correlation was used in analyses.

Results: bFGF-containing implants induced MVD of eight, 35, 42, and 42 vessels per square millimeter on days 3, 6, 9, and 12, respectively; in controls, MVD was four vessels/mm² (P < .05 on days 6, 9, and 12). bFGF-containing implants induced percentage MVA of 2%, 5%, 20%, and 27%, respectively; in controls, it was 0.5% (P < .05). Maximum enhancement was significantly increased in bFGF implants (23.3 gray level ± 14.1 [standard deviation]) compared with controls (11.0 ± 5.5, P < .001). Implants containing bFGF showed poor correlations between fractional blood volume and MVD (r² = 0.42) or percentage MVA (r² = 0.51) at US. There was no correlation between microbubble velocity and MVD (r² < 0.05) or percentage MVA (r² < 0.13).

Conclusion: Functional US perfusion parameters do not correlate with current histologic indices for quantifying angiogenesis. MVD, as a histologic quantitative measurement of angiogenesis, may not be an appropriate standard for contrast-enhanced imaging that relies on perfused neovessels.

© RSNA, 2006

This article has been cited by other articles:

				M. E. Loveless, X. Li, J. Huamani, A. Lyshchik, B. Dawant, D. Hallahan, J. C. Gore, and T. E. Yankeelov A Method for Assessing the Microvasculature in a Murine Tumor Model Using Contrast-Enhanced Ultrasonography J. Ultrasound Med., December 1, 2008; 27(12): 1699 - 1709. [Abstract] [Full Text] [PDF]

				D. J. Lee, A. Lyshchik, J. Huamani, D. E. Hallahan, and A. C. Fleischer Relationship Between Retention of a Vascular Endothelial Growth Factor Receptor 2 (VEGFR2)-Targeted Ultrasonographic Contrast Agent and the Level of VEGFR2 Expression in an In Vivo Breast Cancer Model J. Ultrasound Med., June 1, 2008; 27(6): 855 - 866. [Abstract] [Full Text] [PDF]

				A. Lyshchik, A. C. Fleischer, J. Huamani, D. E. Hallahan, M. Brissova, and J. C. Gore Molecular Imaging of Vascular Endothelial Growth Factor Receptor 2 Expression Using Targeted Contrast-Enhanced High-Frequency Ultrasonography J. Ultrasound Med., November 1, 2007; 26(11): 1575 - 1586. [Abstract] [Full Text] [PDF]